Untreated Adult Acute Myeloid Leukemia Recruiting Phase 2 Trials for Nilotinib (DB04868)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01690065Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AMLTreatment